| SC 13D/A | 2022-03-11 | TVM Life Science Innovation I L.P. | Centogene N.V. | 1,632,606 | 6.0% | EDGAR |
| SC 13D/A | 2022-02-22 | DPE Deutsche Private Equity Gesellschaft mbH | Centogene N.V. | 8,241,315 | 29.9% | EDGAR |
| SC 13G | 2021-12-09 | PLATINUM INVESTMENT MANAGEMENT LTD | Centogene N.V. | - | - | EDGAR |
| SC 13D/A | 2021-05-12 | DPE Deutsche Private Equity Gesellschaft mbH | Centogene N.V. | 6,036,287 | 27.3% | EDGAR |
| SC 13G/A | 2021-02-16 | Rolfs Arndt | Centogene N.V. | 2,239,612 | 10.0% | EDGAR |
| SC 13D/A | 2020-11-05 | DPE Deutsche Private Equity Gesellschaft mbH | Centogene N.V. | 5,599,655 | 25.6% | EDGAR |
| SC 13D/A | 2020-11-03 | TVM Life Science Innovation I L.P. | Centogene N.V. | 1,632,606 | 7.5% | EDGAR |
| SC 13D/A | 2020-08-10 | DPE Deutsche Private Equity Gesellschaft mbH | Centogene N.V. | 5,124,289 | 23.4% | EDGAR |
| SC 13D | 2020-02-14 | Careventures Fund II GP S. a. r. l. | Centogene N.V. | 3,249,093 | 16.4% | EDGAR |
| SC 13G | 2020-02-12 | Rolfs Arndt | Centogene N.V. | 2,401,978 | 12.1% | EDGAR |
| SC 13D | 2020-01-14 | TVM Life Science Innovation I L.P. | Centogene N.V. | 1,934,105 | 9.7% | EDGAR |
| SC 13D | 2019-11-22 | DPE Deutsche Private Equity Gesellschaft mbH | Centogene N.V. | 5,124,289 | 25.8% | EDGAR |